Cryoablation Versus Radiofrequency Ablation

This study has been terminated.
Sponsor:
Information provided by:
Children's Healthcare of Atlanta
ClinicalTrials.gov Identifier:
NCT00238823
First received: October 12, 2005
Last updated: May 22, 2007
Last verified: May 2007

October 12, 2005
May 22, 2007
January 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00238823 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cryoablation Versus Radiofrequency Ablation
A Review and Comparison of Cryoablation and Radiofrequency Ablation in Children

The purpose of this retrospective study is to describe why and when we used cryo and why we crossed over when we used both RFA and cryo. It is also to determine if there is some predictor that would make us say one patient would be better served with one technique than another and to describe our overall acute success rate and then our 6-month recurrence rate with cryo ablation and compare it to our known success rate with RFA.

Cryotherapy (Cryo) is a new ablation energy source used instead of the radiofrequency (RFA) method for ablation of septal pathways. In the past year, we have used cryo approximately 50 times, however 50% of the cryo procedures crossed over from RFA to cryo or cryo to RFA. It appears to me that cryo use should be as an adjunct therapy to RFA instead of replacement of RFA.

I would like to describe why and when we used cryo and why we crossed over when we used both RFA and cryo. I would like to determine if there is some predictor that would make us say one patient would be better served with one technique than another. I would also describe our overall acute success rate and then our 6-month recurrence rate with cryo ablation and compare it to our known success rate with RFA. All of this can be done with a chart review.

This will be done through a retrospective study.

Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective
Not Provided
Not Provided
Not Provided
Not Provided
Congenital Disorders
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
50
December 2004
Not Provided

Inclusion Criteria:

  • charts between January 1 and 2004 to December 31, 2004
  • pediatric population
  • those who were ablated

Exclusion Criteria:

-

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00238823
05-108
Not Provided
Not Provided
Children's Healthcare of Atlanta
Not Provided
Principal Investigator: Margaret Strieper, DO Sibley Heart Center
Children's Healthcare of Atlanta
May 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP